These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38861665)

  • 1. Correction to Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.
    Hematol Oncol; 2024 Jul; 42(4):e3291. PubMed ID: 38861665
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.
    Zilioli VR; Cencini E; Lorenzo S; Pezzullo L; Merli M; Rivellini F; Muzi C; Emiliano B; Marcheselli L; Luminari S
    Hematol Oncol; 2024 May; 42(3):e3273. PubMed ID: 38661120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
    Bair SM; Strelec LE; Feldman TA; Ahmed G; Armand P; Shah NN; Singavi AN; Reddy N; Khan N; Andreadis C; Vu K; Huntington SF; Giri S; Ujjani C; Howlett C; Faheem M; Youngman MR; Nasta SD; Landsburg DJ; Schuster SJ; Svoboda J
    Oncologist; 2019 Jul; 24(7):955-962. PubMed ID: 30568021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Experience of PD-1 Inhibitors for Relapsed and Refractory Hodgkin Lymphoma: A Multicenter Retrospective Analysis of Patients in China.
    Yu W; Geng M; Hao J; Yan Z; Mi JQ
    Acta Haematol; 2023; 146(4):307-315. PubMed ID: 37023729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).
    Wirth A; Prince HM; Roos D; Gibson J; O'Brien P; Zannino D; Khodr B; Stone JM; Davis S; Hertzberg M
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1158-1166. PubMed ID: 30553941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.
    Gandolfi L; Pellegrini C; Casadei B; Stefoni V; Broccoli A; Tonialini L; Morigi A; Argnani L; Zinzani PL
    Oncologist; 2016 Dec; 21(12):1436-1441. PubMed ID: 27486201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
    Russell J; Collins A; Fowler A; Karanth M; Saha C; Docherty S; Padayatty J; Maw K; Lentell I; Cooke L; Hodson A; Shah N; Sadullah S; Grigoropoulos N; Qian W; Kirkwood AA; Uttenthal BJ; Johnson P; Follows GA
    Ann Hematol; 2021 Apr; 100(4):1049-1058. PubMed ID: 33641019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience.
    Moretti M; Liberati AM; Rigacci L; Puccini B; Pulsoni A; Gini G; Galieni P; Fabbri A; Cantonetti M; Pavone V; Bolis S; Botto B; Renzi D; Falchi L
    Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):198-204. PubMed ID: 34690088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina.
    Mahuad C; Victoria O; Laura K; Enriqueta M; Fernando W; Hernán GR; Nancy C; Dana K; Marta Z; Gonzalo G; de Los Ángeles VRM; Florencia A; Erica RB; Susana C; Eugenia FM; Iliana P; Cecilia F; Anahí VB; Santiago C; Adriana V; Mariela G; Justina L; Claudia C; Manuela C; Luciana M; Cecilia CLM; Augusto M; Laura F; Maximiliano P; Marcela M; Silvana C
    Clin Hematol Int; 2022 Jun; 4(1-2):44-51. PubMed ID: 35950206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
    Sickinger MT; von Tresckow B; Kobe C; Engert A; Borchmann P; Skoetz N
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010533. PubMed ID: 25572491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
    Vijenthira A; Chan K; Cheung MC; Prica A
    Lancet Haematol; 2020 Feb; 7(2):e146-e156. PubMed ID: 31948928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-Based Treatment in Poor-Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma--a Multicenter Polish Experience.
    Rybka J; Jurczak W; Giza A; Paszkiewicz-Kozik E; Kumiega B; Drozd-Sokołowska J; Butrym A; Kuliczkowski K; Wróbel T
    Adv Clin Exp Med; 2015; 24(5):783-9. PubMed ID: 26768628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
    Bröckelmann PJ; Goergen H; Fuchs M; Kriz J; Semrau R; Baues C; Kobe C; Behringer K; Eichenauer DA; von Tresckow B; Klimm B; Halbsguth T; Wongso D; Plütschow A; Haverkamp H; Dietlein M; Eich HT; Stein H; Diehl V; Borchmann P; Engert A
    Br J Haematol; 2015 Nov; 171(4):547-56. PubMed ID: 26310520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM; Nadel HR; Shulkin BL; Cho SY
    Pediatr Radiol; 2019 Oct; 49(11):1545-1564. PubMed ID: 31620854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.
    Zinzani PL; Broccoli A; Gioia DM; Castagnoli A; Ciccone G; Evangelista A; Santoro A; Ricardi U; Bonfichi M; Brusamolino E; Rossi G; Anastasia A; Zaja F; Vitolo U; Pavone V; Pulsoni A; Rigacci L; Gaidano G; Stelitano C; Salvi F; Rusconi C; Tani M; Freilone R; Pregno P; Borsatti E; Sacchetti GM; Argnani L; Levis A
    J Clin Oncol; 2016 Apr; 34(12):1376-85. PubMed ID: 26884559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].
    Garciaz S; Coso D; Brice P; Bouabdallah R
    Bull Cancer; 2016 Dec; 103(12):1035-1049. PubMed ID: 27866679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging.
    Bair SM; Svoboda J
    PET Clin; 2019 Jul; 14(3):353-368. PubMed ID: 31084775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
    Casasnovas RO; Bouabdallah R; Brice P; Lazarovici J; Ghesquieres H; Stamatoullas A; Dupuis J; Gac AC; Gastinne T; Joly B; Bouabdallah K; Nicolas-Virelizier E; Feugier P; Morschhauser F; Delarue R; Farhat H; Quittet P; Berriolo-Riedinger A; Tempescul A; Edeline V; Maisonneuve H; Fornecker LM; Lamy T; Delmer A; Dartigues P; Martin L; André M; Mounier N; Traverse-Glehen A; Meignan M
    Lancet Oncol; 2019 Feb; 20(2):202-215. PubMed ID: 30658935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy response evaluation of malignant lymphoma in a multicenter study: comparison of manual and semiautomatic measurements in CT.
    Weßling J; Schülke C; Koch R; Kohlhase N; Wassenaar L; Mesters R; Höink AJ; D Anastasi M; Karpitschka M; Fabel M; Wulff AM; Pinto dos Santos D; Kiessling A; Graser A; Bornemann L; Dicken V; Heindel W; Buerke B
    Rofo; 2014 Aug; 186(8):768-79. PubMed ID: 24497088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance imaging in pediatric lymphoma.
    Voss SD; Cairo MS
    Pediatr Radiol; 2019 Oct; 49(11):1565-1573. PubMed ID: 31620855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.